arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

COLLEGIUM PHARMACEUTICAL, INC

COLL

$29.48 ▲ +0.36 (+1.22%) at close

14 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

COLLEGIUM PHARMACEUTICAL, INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $934.7M

Dividend Yield —

Revenue Growth 23.6% ↗

Op. Margin 23.0% ↘

ROIC 40.4% ↘

FCF / Share $10.33 ↗

Trailing P/E 14.9x

Price / Book 3.1x

FCF Yield 35.1%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$780.57M

↑ +23.6% —

Net Income Profit after all expenses

$62.87M

↓ -9.1% —

Operating Margin Operating profit as % of sales

23.0%

↓ -14.5% 79th

FCF / Share Free cash flow per share

$10.33

↑ +64.0% —

Long-Term Debt Long-term obligations

$11.50M

↑ +177.4% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	23.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+195%)	11.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+43%)	22.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+177%)	67.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+745%)	-10.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-234%)	4.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-44%)	5.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-27%)	884.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10959%)	1564.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19454%)	—	—	—	—	—
EPS Growth YoY (%)	-7.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	49.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	162.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	-162.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	-9.1% Weak Weak Year-over-year change in net income	43.7% Excellent Excellent Year-over-year change in net income	N/M	N/M	167.3% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	41.9% Excellent ↑ Excellent Improving Year-over-year change in net income	47.7% Excellent ↑ Excellent Improving Year-over-year change in net income	20.5% Good ↑ Good Improving Year-over-year change in net income	-245.5% Weak ↓ Weak Declining Year-over-year change in net income	-52.1% Weak Weak Year-over-year change in net income	-10.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	64.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-22.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	124.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	24.6% Good ↓ Good Declining Year-over-year change in free cash flow	13.2% Fair Fair Year-over-year change in free cash flow	302.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	18.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	31.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	16.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	-0.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	121.6% Excellent Excellent Compound annual revenue growth over 3 years	457.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	20.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	16.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	15.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	74.7% Excellent Excellent Compound annual revenue growth over 5 years	176.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	1.4% Caution Caution Compound annual EPS growth over 3 years	22.4% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	23.0% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+53%)	26.9% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+79%)	29.5% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+96%)	7.2% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-52%)	6.4% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-58%)	18.1% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+21%)	-8.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-153%)	-7.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-149%)	-264.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1866%)	—	—	—	—	—
Effective Tax Rate (%) (%)	32.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	29.8% Caution ↓ Caution Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	36.4% Weak ↓ Weak Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2219.7% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	8.1% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-33%)	11.0% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	8.5% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-29%)	-5.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-145%)	25.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+115%)	8.6% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-28%)	-7.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-164%)	-14.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-216%)	-262.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2291%)	—	—	—	—	—
FCF Margin (%) (%)	42.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	32.2% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	48.4% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	26.4% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	36.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	28.5% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	7.2% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	58.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-238.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	5.21x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.94x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	5.70x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-4.90x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	3.30x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.94x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-4.19x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	40.4% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	52.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	54.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.8% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-184.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	29.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	18.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	10.8% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	10.2% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	14.6% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	2.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	8.7% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-347.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	20.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+39%)	30.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+102%)	24.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+64%)	-12.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	35.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+135%)	14.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-26.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-273%)	-42.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)	-71.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-580%)	-69.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-565%)	-32.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-314%)	20.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	23.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+58%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	—	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	—	—	—	—
Interest Coverage (x)	2.61x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	2.72x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	2.00x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	0.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	0.84x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	1.95x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-26.13x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.03x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-542.78x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1000.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	-61.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-231.25M	$-70.56M	$-238.95M	$-173.69M	$-186.43M	$-174.12M	$-170.02M	$-135.13M	$-118.70M	$-149.08M	$-95.70M	$-1.63M	$-7.55M	$-11.94M
Debt / EBITDA (x)	—	—	—	—	—	—	—	-0.59x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.04x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$24.62	$19.57	$16.80	$13.71	$7.92	$9.01	$8.87	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$1.98	$2.14	$1.43	$-0.74	$2.05	$0.78	$-0.68	—	—	$-3.88	$-1.48	—	—	—
Free Cash Flow per Share (USD)	$10.33	$6.30	$8.13	$3.62	$2.91	$2.57	$0.64	—	—	—	—	—	—	—
Book Value per Share (USD)	$9.51	$7.28	$6.13	$5.76	$6.03	$5.37	$2.60	$2.75	$3.18	$4.59	$4.10	$-88.80	$-70.85	—
Tangible Book Value per Share (USD)	$-16.20	$-26.24	$-11.30	$-14.96	$-1.95	$5.37	$2.60	$2.75	$3.18	$4.59	$4.10	$-88.80	$-70.85	—
Basic Weighted Avg Shares (shares)	31.71M	32.27M	33.74M	33.83M	34.94M	34.41M	33.45M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$251.38M	$-27.25M	$79.69M	$-13.74M	$35.98M	$38.44M	$53.95M	$48.39M	$102.00M	$132.98M	$88.45M	$-5.92M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	$11.50M	—	$4.15M	—	—	—	—
Total Equity (USD)	$301.68M	$228.84M	$195.43M	$194.84M	$202.93M	$186.03M	$87.43M	$91.58M	$104.08M	$134.91M	$85.07M	$-89.35M	$-68.22M	$-61.40M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$780.57M	$631.45M	$566.77M	$463.93M	$276.87M	$310.02M	$296.70M	$280.41M	$28.48M	$1.71M	—	—	—	—
Depreciation Expense (USD)	$4.18M	$3.86M	$3.50M	$2.68M	$1.74M	$870.00K	$731.00K	$1.07M	$594.00K	$655.00K	$171.00K	$187.00K	$169.00K	—
Net Income, GAAP (USD)	$62.87M	$69.19M	$48.16M	$-25.00M	$71.52M	$26.75M	$-22.72M	$-39.13M	$-74.86M	$-94.18M	$-27.25M	$-17.92M	$-16.20M	—
Operating Cash Flow (USD)	$329.32M	$204.98M	$274.75M	$124.23M	$103.56M	$93.94M	$27.78M	$169.39M	$-67.02M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters

COLLEGIUM PHARMACEUTICAL, INC

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare COLL with peers